BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37788852)

  • 1. Choosing the Right Metrics for Evaluation of Radiopharmaceutical Therapy Dosimetry Methodologies.
    Scheuermann JS; Pryma DA
    J Nucl Med; 2023 Oct; 64(10):1617-1618. PubMed ID: 37788852
    [No Abstract]   [Full Text] [Related]  

  • 2. Uncertainties in internal dose calculations for radiopharmaceuticals.
    Stabin MG
    J Nucl Med; 2008 May; 49(5):853-60. PubMed ID: 18413398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RADAR Guide: Standard Methods for Calculating Radiation Doses for Radiopharmaceuticals, Part 1-Collection of Data for Radiopharmaceutical Dosimetry.
    Stabin MG; Wendt RE; Flux GD
    J Nucl Med; 2022 Feb; 63(2):316-322. PubMed ID: 34353875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetry in Radiopharmaceutical Therapy.
    O'Donoghue J; Zanzonico P; Humm J; Kesner A
    J Nucl Med; 2022 Oct; 63(10):1467-1474. PubMed ID: 36192334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic and locoregional dosimetry in receptor radionuclide therapy with peptides.
    Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):288-95. PubMed ID: 17043626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs.
    Bodei L; Michael Tuttle R; Grewal RK; Mauguen A; Augensen F; Abusamra M; Mahajan S; Jayaprakasam VS; Osborne JR; Haque S; Wong BZY; Ghossein RA; Fagin J; Schӧder H; Ho A; Humm JL; Larson SM
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):325-329. PubMed ID: 37712994
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings of the 2nd International Symposium on Radionuclide Therapy and Radiopharmaceutical Dosimetry, Athens, Greece, 2006.
    Cancer Biother Radiopharm; 2007 Feb; 22(1):103-74. PubMed ID: 17627417
    [No Abstract]   [Full Text] [Related]  

  • 8. The Case for Dosimetry in Alpha-Emitter Therapy.
    Sgouros G
    J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S45-S46. PubMed ID: 31537496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A persistent belief in radiopharmaceutical therapy.
    Sgouros G
    Med Phys; 2023 Jun; 50 Suppl 1():104-108. PubMed ID: 36774195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates.
    Siegel JA; Thomas SR; Stubbs JB; Stabin MG; Hays MT; Koral KF; Robertson JS; Howell RW; Wessels BW; Fisher DR; Weber DA; Brill AB
    J Nucl Med; 1999 Feb; 40(2):37S-61S. PubMed ID: 10025848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MIB Guides: Preclinical Radiopharmaceutical Dosimetry.
    Carter LM; Zanzonico PB
    Mol Imaging Biol; 2024 Feb; 26(1):17-28. PubMed ID: 37964036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetry for radiopharmaceutical therapy.
    Sgouros G; Hobbs RF
    Semin Nucl Med; 2014 May; 44(3):172-8. PubMed ID: 24832581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the Use of Artificial Intelligence for Dosimetry of Radiopharmaceutical Therapies.
    Brosch-Lenz JF; Delker A; Schmidt F; Tran-Gia J
    Nuklearmedizin; 2023 Dec; 62(6):379-388. PubMed ID: 37827503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIRD pamphlet No. 20: the effect of model assumptions on kidney dosimetry and response--implications for radionuclide therapy.
    Wessels BW; Konijnenberg MW; Dale RG; Breitz HB; Cremonesi M; Meredith RF; Green AJ; Bouchet LG; Brill AB; Bolch WE; Sgouros G; Thomas SR
    J Nucl Med; 2008 Nov; 49(11):1884-99. PubMed ID: 18927342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiopharmaceutical therapy in the era of precision medicine.
    Sgouros G; Goldenberg DM
    Eur J Cancer; 2014 Sep; 50(13):2360-3. PubMed ID: 24953565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIRD Pamphlet No. 28, Part 2: Comparative Evaluation of MIRDcalc Dosimetry Software Across a Compendium of Diagnostic Radiopharmaceuticals.
    Carter LM; Ocampo Ramos JC; Olguin EA; Brown JL; Lafontaine D; Jokisch DW; Bolch WE; Kesner AL
    J Nucl Med; 2023 Aug; 64(8):1295-1303. PubMed ID: 37268423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Monte Carlo approach to small-scale dosimetry of solid tumour microvasculature for nuclear medicine therapies with (223)Ra-, (131)I-, (177)Lu- and (111)In-labelled radiopharmaceuticals.
    Amato E; Leotta S; Italiano A; Baldari S
    Phys Med; 2015 Jul; 31(5):536-41. PubMed ID: 25979209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives on Internal Dosimetry for Optimized Radionuclide Therapy.
    Fisher DR
    Cancer Biother Radiopharm; 2022 Apr; 37(3):161-163. PubMed ID: 34569812
    [No Abstract]   [Full Text] [Related]  

  • 19. EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting.
    Lassmann M; Chiesa C; Flux G; Bardiès M;
    Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):192-200. PubMed ID: 20799035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RADAR Guide: Standard Methods for Calculating Radiation Doses for Radiopharmaceuticals, Part 2-Data Analysis and Dosimetry.
    Stabin MG; Wendt RE; Flux GD
    J Nucl Med; 2022 Mar; 63(3):485-492. PubMed ID: 34353873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.